logo

For the Inventor, By the Inventor

The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Patent No.:

US 8815286 B1

PDFFull Text
Date of Patent:
Aug. 26, 2014

Filed:

Jul. 23, 2009

Pharmaceutical composition for treating hypertension and metabolic syndrome and use thereof

Applicant:

Zhiquan Zhao, Linyi, CN;

Inventor:

Zhiquan Zhao, Linyi, CN;

Assignee:

Lunan Pharmaceutical Group Corporation, Linyi, Shandong Province, CN;

Attorney:

Renner, Otto, Boisselle & Sklar, LLP

Primary Examiner:

Scott Long

Assistant Examiner:

Lyndsey Beckhardt

Int. Cl.
CPC ...
A61K 9/20 (2006.01); A01N 43/00 (2006.01); A61K 31/50 (2006.01); A61K 9/48 (2006.01); A61K 31/4184 (2006.01); A61K 45/06 (2006.01); A61K 31/505 (2006.01); A61K 31/519 (2006.01); A61K 31/4439 (2006.01); A61K 31/4178 (2006.01); A61K 9/16 (2006.01); A61K 31/41 (2006.01); A61K 9/00 (2006.01); A61K 9/24 (2006.01);
U.S. Cl.
CPC ...
A61K 9/4866 (2013.01); A61K 31/4184 (2013.01); A61K 45/06 (2013.01); A61K 31/505 (2013.01); A61K 31/519 (2013.01); A61K 31/4439 (2013.01); A61K 31/4178 (2013.01); A61K 9/1623 (2013.01); A61K 31/41 (2013.01); A61K 9/2059 (2013.01); A61K 9/485 (2013.01); A61K 9/0056 (2013.01); A61K 9/209 (2013.01); A61K 9/2027 (2013.01); A61K 9/20 (2013.01); A61K 9/2054 (2013.01); A61K 9/1652 (2013.01);
Abstract

The present invention provides a pharmaceutical composition comprising the following active ingredients: 1) an angiotensin II receptor antagonist or a pharmaceutically acceptable salt thereof, 2) pioglitazone or a pharmaceutically acceptable salt thereof; and 3) rosuvastatin or a pharmaceutically acceptable salt thereof. The present invention also provides use of the pharmaceutical composition in preparing a medicament for treating hypertension or metabolic syndrome. The pharmaceutical composition of the present invention can treat hypertension or metabolic syndrome, while effectively controlling the incidence of associated cardiovascular diseases and more potently improving survival prognosis in hypertensive patients. When blood pressure is lowered to desired level, the risk factors such as cardiovascular diseases are rectified, metabolic disorders and prognosis of patients are improved, and survival rate of hypertensive patients is raised.

Find Patent Forward Citations

Loading…